These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10217912

  • 1. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ, Bordeaux B, Leshner RT.
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [Abstract] [Full Text] [Related]

  • 2. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A, Frascarelli M, Uccini S, Novelli A.
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [Abstract] [Full Text] [Related]

  • 3. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E, Poulton J, Buck J, Broadbent V, Bamford M, Jungbluth H, Manzur AY, Muntoni F.
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [Abstract] [Full Text] [Related]

  • 4. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B, Pediatric Oncology Group Study.
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [Abstract] [Full Text] [Related]

  • 5. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G.
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [Abstract] [Full Text] [Related]

  • 6. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y, Toren A, Rechavi G, Seifried B, Shoham NG, Mandel M, Kenet G, Sharon N, Sadeh M, Navon R.
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD, Smith AA, Odom LF.
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract] [Full Text] [Related]

  • 10. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T, Altintas A, Tamam Y, Battaloğlu E, Isikdogan A.
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease.
    Dickerhoff R, Lindner W, Scheiber W.
    Pediatr Hematol Oncol; 1988 Oct; 5(1):61-4. PubMed ID: 3152952
    [No Abstract] [Full Text] [Related]

  • 13. Charcot-Marie-Tooth disease and vincristine.
    Orejana-García AM, Pascual-Huerta J, Pérez-Melero A.
    J Am Podiatr Med Assoc; 2003 Oct; 93(3):229-33. PubMed ID: 12756314
    [Abstract] [Full Text] [Related]

  • 14. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.
    Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD.
    Cancer; 1996 Apr 01; 77(7):1356-62. PubMed ID: 8608515
    [Abstract] [Full Text] [Related]

  • 15. Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.
    Nakamura T, Hashiguchi A, Suzuki S, Uozumi K, Tokunaga S, Takashima H.
    Neurogenetics; 2012 Feb 01; 13(1):77-82. PubMed ID: 22271166
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS, Riggs JE.
    Ann Pharmacother; 2000 Oct 01; 34(10):1136-8. PubMed ID: 11054980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.